Premium
Implanon: A Review of the Literature With Recommendations for Clinical Management
Author(s) -
Adams Kate,
Beal Margaret W.
Publication year - 2009
Publication title -
journal of midwifery and women's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.543
H-Index - 62
eISSN - 1542-2011
pISSN - 1526-9523
DOI - 10.1016/j.jmwh.2008.09.004
Subject(s) - medicine , contraceptive implant , clinical trial , family planning , obstetrics , surgery , population , research methodology , environmental health
Implanon is a new implantable, progestin‐only contraceptive which was approved in the United States in July 2006. Implanon is comprised of a single ethylene vinylacetate copolymer rod that is 4 cm long and 2 mm in diameter. It is inserted subdermally in the groove between the biceps and triceps of the nondominant arm. A literature review was conducted and side effects are discussed. Implanon offers promise as a high‐efficacy, long‐term contraceptive and can enhance the contraceptive options offered by the women's health care providers. Clinical trial data indicate that the device is both safe and effective.